Publication | Closed Access
A Phase I intermittent dose-escalation trial of ZD1839 (IressaTM) in Japanese patients with solid malignant tumors
17
Citations
0
References
2000
Year
Japanese PatientsOncologyRadiation TherapyMetronomic TherapyPharmacotherapyDose-escalation TrialCancer TreatmentMedicineRadiation OncologySolid Malignant TumorsRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!